Shira Abberbock
Papers
4
Total Citations
192
H-Index
4
About
Shira Abberbock is a leading clinical researcher in head and neck surgical oncology, with a focused expertise in transoral robotic surgery (TORS) for oropharyngeal cancer. Her work has fundamentally advanced the understanding of how robotic surgery can be used as a standalone treatment, helping patients avoid the long-term toxicities of adjuvant radiotherapy and chemotherapy. Her most influential study (76 citations) provided critical evidence that TORS alone can achieve favorable quality-of-life outcomes, challenging the prevailing standard of combined-modality therapy. Abberbock further characterized the perioperative swallowing difficulties unique to TORS, offering surgeons a clearer roadmap for managing short-term dysphagia (50 citations). She also demonstrated how up-front TORS can be leveraged to tailor adjuvant therapy precisely to individual pathology, thereby reducing overtreatment (37 citations). Her investigation into positive margin rates across oropharyngeal subsites (29 citations) identified key anatomical and imaging predictors of surgical success, directly informing preoperative planning. Through these contributions, Abberbock has helped shape a more patient-centered, de-escalation approach to oropharyngeal cancer care, establishing TORS as a viable, function-preserving alternative to chemoradiation.
Research Focus
Key Achievements
Top Papers
- 1Transoral Robotic Surgery Alone for Oropharyngeal Cancer76 citations · 2015
- 2
- 3Utility of up‐front transoral robotic surgery in tailoring adjuvant therapy37 citations · 2016
- 4